crohn's and glp 1 Pharmacological interventions for obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy safety GLP-1 medications help with Crohn's

Supports healthy digestion and regularity*

Background The worldwide rise in overweight and obesity is paralleled by an increasing prevalence of type-2 diabetes

Discover how PlexusDx personalized semaglutide therapy addresses both conditions safely

Both insulin and GLP-1RAs have shown optimal glucose-lowering and anti-inflammatory effects in type 2 diabetic patients and may represent a valid therapeutic option to treat asymptomatic and non-critically ill COVID-19 diabetic patients.

Learn why hydration matters, how heat can affect side effects, and when to contact a medical provider.

Are TikTok-viral yerba mate powders the same as real yerba mate